BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30802770)

  • 1. High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.
    Ullah M; Azazzen D; Kaci R; Benabbou N; Pujade Lauraine E; Pocard M; Mirshahi M
    Neoplasia; 2019 Mar; 21(3):331-342. PubMed ID: 30802770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression.
    Lin A; Xu HH; Xu DP; Zhang X; Wang Q; Yan WH
    Hum Immunol; 2013 Apr; 74(4):439-46. PubMed ID: 23228395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G expression in human ovarian carcinoma counteracts NK cell function.
    Lin A; Yan WH; Xu HH; Gan MF; Cai JF; Zhu M; Zhou MY
    Ann Oncol; 2007 Nov; 18(11):1804-9. PubMed ID: 17846022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
    Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
    Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G.
    Melsted WN; Matzen SH; Andersen MH; Hviid TVF
    Cell Immunol; 2018 Feb; 324():14-23. PubMed ID: 29198970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation.
    Bondong S; Kiefel H; Hielscher T; Zeimet AG; Zeillinger R; Pils D; Schuster E; Castillo-Tong DC; Cadron I; Vergote I; Braicu I; Sehouli J; Mahner S; Fogel M; Altevogt P
    Ann Oncol; 2012 Jul; 23(7):1795-802. PubMed ID: 22228447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
    Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
    Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Killer Cell Cytotoxicity Against SKOV3 after HLA-G Downregulation by shRNA.
    Nazari N; Farjadian S
    Iran J Immunol; 2016 Sep; 13(3):178-85. PubMed ID: 27671509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
    Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
    Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
    Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preimplantation Factor (PIF) Promotes HLA-G, -E, -F, -C Expression in JEG-3 Choriocarcinoma Cells and Endogenous Progesterone Activity.
    Hakam MS; Miranda-Sayago JM; Hayrabedyan S; Todorova K; Spencer PS; Jabeen A; Barnea ER; Fernandez N
    Cell Physiol Biochem; 2017; 43(6):2277-2296. PubMed ID: 29073617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesion HLA-G5/-G6 isoforms expression in patients with ovarian cancer.
    Zhang X; Han QY; Li JB; Ruan YY; Yan WH; Lin A
    Hum Immunol; 2016 Sep; 77(9):780-4. PubMed ID: 26687271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients.
    Jeong S; Park S; Park BW; Park Y; Kwon OJ; Kim HS
    PLoS One; 2014; 9(5):e98284. PubMed ID: 24870375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenesis of ovarian cancer.
    Torres MP; Ponnusamy MP; Lakshmanan I; Batra SK
    Minerva Med; 2009 Oct; 100(5):385-400. PubMed ID: 19910891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
    Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS
    J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.